NCT05078372View on ClinicalTrials.gov

Ropivacaine and Midazolam by Intraarticular vs Epidural Administration in Arthroscopic ACL

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

January 31, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

February 5, 2021

Conditions
Anterior Cruciate Ligament InjuriesAnesthesia Injection SiteKnee Injuries
Interventions
DRUG

ropivacaine and midazolam intraarticular administration

Patients undergoing ACL reconstruction with hamstring autograft who will receive ropivacaine and midazolam epidural administration for anesthesic technique for the procedure, and intraarticular administration of those drugs.

DRUG

ropivacaine and midazolam epidural administration

Patients undergoing ACL reconstruction with hamstring autograft who will receive ropivacaine and midazolam epidural administration for anesthesic technique for the procedure

Trial Locations (1)

64460

Universidad Autonoma de Nuevo Leon, Monterrey

All Listed Sponsors
collaborator

Universitat Autonoma de Barcelona

OTHER

lead

Universidad Autonoma de Nuevo Leon

OTHER

NCT05078372 - Ropivacaine and Midazolam by Intraarticular vs Epidural Administration in Arthroscopic ACL | Biotech Hunter | Biotech Hunter